Tag: FDA warning letter

Multilevel distributors of the dietary supplement Protandim think that evidence from scientific studies supports their claims for their product. The FDA disagrees. The FDA identifies mislabeling and false claims On April 17, 2017, the FDA sent a warning letter to the LifeVantage Corporation advising them that their product Protandim NRF2… read more "Protandim Update: New Studies and an FDA Warning Letter"